COMMUNIQUÉS West-GlobeNewswire

-
SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients at the 2024 European School of Haematology (ESH) Conference
25/01/2024 -
Bright Green Corporation announces the agreement to acquire platform technologies and associated intellectual property from C2 Wellness Corp.
25/01/2024 -
Windtree Eliminates $15 Million Contingent Liability to Deerfield Management Company
25/01/2024 -
NightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical Program
25/01/2024 -
Intelligent Bio Solutions Inc. Announces Reverse Stock Split
25/01/2024 -
Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 Doses
25/01/2024 -
Veru to Report Fiscal 2024 First Quarter Financial Results on February 8, 2024
25/01/2024 -
Evaxion développe de nouveaux vaccins personnalisés contre le cancer basés sur une nouvelle source inexploitée de cibles découvertes par l’IA
25/01/2024 -
Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis Congress
25/01/2024 -
Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference
25/01/2024 -
Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis
25/01/2024 -
Ocular Therapeutix™ Announces FDA Agreement to Amend Special Protocol Assessment (SPA) for Pivotal Clinical Trial of AXPAXLI™ in Wet AMD
25/01/2024 -
Kronos Bio Implements New Leadership Structure to Drive Pipeline Advancement
25/01/2024 -
eFFECTOR Therapeutics Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
25/01/2024 -
Bionano Announces Publication of a Study that Applied OGM to Discovery of Structural Variants Driving Drug Resistance and Sensitivity in Cancer
25/01/2024 -
SS Innovations Partners with India’s Leading Medical Equipment Supplier, Medikabazaar
25/01/2024 -
Cytokinetics Presents New Data at CMR 2024 From FOREST-HCM, the Open Label Extension Clinical Trial of Aficamten
25/01/2024 -
InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients
25/01/2024 -
ALK’s European registration application for house dust mite SLIT-tablet in young children accepted for review
25/01/2024
Pages